Timeline – isoSolutions

2000 — Founded isoSolutions Inc. (consulting company).
2001 — Founded isoSolutions Marketing & Management Inc.(product distribution company).
2002 — isoSolutions was co-founder of Cyclomedical Applications Group, a company providing medical cyclotron facility services and contract management.
2002 — isoSolutions was co-founder of Alpha IICH Inc., a company developing a supply of alpha emitting radioisotopes for radiotherapy.
2003 — Established Area Sales Manager for Latin American market.
2005 — Formed partnership with Vira Pharma GmbH, a German company that managed the European market while isoSolutions managed the North and South American markets.
2007 — Headquarters of isoSolutions moved from Ottawa, Ontario to Vancouver, British Columbia.
2008 — Appointed Marketing & Sales Manager, Asia.
2009 — Initiated marketing activities in China.
2012 — First exhibit at Society of Nuclear Medicine and Molecular Imaging Annual Meeting (Miami Beach).
2013 — Hired Executive Assistant to Managing Director.
2013 — Established new office space in West End of Vancouver.
2013 — Hired Marketing & Sales Manager, Latin America.
2013 — isoSolutions sponsors an annual Armstrong-Lepeska Science Marketing Scholarship at Langara College.
2014 — Hired Marketing & Sales Manager, Canada/USA.
2014 — First exhibit at Canadian Association of Nuclear Medicine (Calgary).
2014 — First exhibit at international congress (World Federation of Nuclear Medicine & Biology, Cancun).
2015 — First ALASBIMN exhibit (Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear, Punta del Este).
2015 — Established Order Desk.
2015 — First exhibit at Brazilian Congress of Nuclear Medicine and Biology (Rio de Janeiro).
2016 — isoSolutions celebrates 15th Anniversary.
2016 — isoSolutions launches re-designed web site
2017 — isoSolutions adds Elysia-raytest to product line
2017 — isoSolutions establishes first sales and marketing manager located in United States
2017 — A Customer Service Manager is appointed with responsibility for supplier and customer relations, order management, and logistics.
2018 — isoSolutions appoints Directors of Marketing & Sales, Customer Service and Administration
2018 — GMP grade non-carrier added Lutetium-177 is added to the product portfolio.
2019 — A new strategic commercial alliance is established with Fenix Medica to strengthen our presence in Latin America.
2019 — A Sales & Marketing Manager for Asia is appointed, expanding the Asian team to three staff.
2019 — isoSolutions exhibits at the International Symposium on Targeted Alpha-Therapy.
2019 — isoSolutions attends the Chinese National Conference of Nuclear Medicine.
2020 — isoSolutions joins the Canadian Nuclear Isotope Council.
2020 — Founder started transition to retirement as Strategic Consultant, and new Managing Director was appointed.
2021 — A dedicated sales and service team was formed for QC instruments portfolio including Elysia-raytest products.
2021 — isoSolutions signs exclusive agreement with QBIOMED to distribute Strontium Sr-89 in Canada.
2021 — isoSolutions signs exclusive agreement with Isotopia to distribute Lutetium Lu-177 in Canada.